JP-1366
Helicobacter pylori Infection
INDClinical trial application submitted
Key Facts
Indication
Helicobacter pylori Infection
Phase
IND
Status
Clinical trial application submitted
Company
About Livzon Pharmaceutical
A major integrated Chinese pharmaceutical group with strong R&D in microsphere technology, biologics, and traditional Chinese medicine.
View full company profileTherapeutic Areas
Other Helicobacter pylori Infection Drugs
| Drug | Company | Phase |
|---|---|---|
| HELIX | Lant Medical | Pre-clinical |
| Helicobacter pylori Treatment | OFD Biopharma | Commercial |
| Linaprazan Glurate | Cinclus Pharma | Unknown |
| TNP-2198 (利福特尼唑) | TenNor Therapeutics | Phase 3 |